Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7100162

Cc1cc(C(=O)NC(=O)CC(=O)O)cc(C)c1OC(=O)c1c2ccccc2[n+](C)c2cc(CN3C(=O)c4ccccc4C3=O)ccc12.O=C([O-])C(F)(F)F

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 3/20 0.33
HDAC1 Q13547 3/20 0.33
TUBB8B A6NNZ2 1/20 0.33
TUBB4A P04350 1/20 0.33
TUBB P07437 1/20 0.33
TUBB4B P68371 1/20 0.33
TUBB3 Q13509 1/20 0.33
TUBB2A Q13885 1/20 0.33
TUBB8 Q3ZCM7 1/20 0.33
HDAC2 Q92769 1/20 0.33
TUBB6 Q9BUF5 1/20 0.33
TUBB2B Q9BVA1 1/20 0.33
TUBB1 Q9H4B7 1/20 0.33
HDAC7 Q8WUI4 2/20 0.33
HDAC4 P56524 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
HDAC9 Q9UKV0 1/20 0.33
HDAC5 Q9UQL6 1/20 0.33
KMT2A Q03164 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8046796 0.84 KMT2A (0.44) HDAC1TUBB8BTUBB4ATUBBTUBB4B
Bromide SCHEMBL7103303 0.83 KMT2A (0.43) HDAC1TUBB8BTUBB4ATUBBTUBB4B
SCHEMBL7099955 0.78 MAPT (0.35) HDAC1TUBB8BTUBB4ATUBBTUBB4B
Trifluoroacetic Acid SCHEMBL7104562 0.77 ACHE (0.30) ACHE
Trifluoroacetic Acid SCHEMBL7102846 0.77 ACHE (0.35) F10ACHEALDH1A1
Trifluoromethanesulfonic Acid SCHEMBL7098580 0.76 ACHE (0.37) KMT2AMAPTTP53LMNAACHE
SCHEMBL7103348 0.74 MAPT (0.35) KMT2AMAPTTP53LMNAACHE
Trifluoroacetic Acid SCHEMBL7193167 0.72 ACHE (0.34) ACHE
Trifluoroacetic Acid SCHEMBL8438517 0.72 ACHE (0.35) KMT2AMAPTACHEALDH1A1MEN1
Trifluoroacetic Acid SCHEMBL4803136 0.69 LMNA (0.37) F10KMT2AMAPTLMNAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0988551-B1 CHEMILUMINESCENT ENERGY TRANSFER CONJUGATES AND THEIR USES AS LABELS IN BINDING ASSAYS BAYER AG (US) 2003-09-10 EP disclosed
US-20030166622-A1 Vitamin D derivatives with acyloxy groups in the side chains, process for their production, and the use for the production of pharmaceutical agents SCHERING AG (DE) 2003-09-04 US disclosed
US-6165800-A Chemiluminescent energy transfer conjugates and their uses as labels in binding assays BAYER CORPORATION (US) 2000-12-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166622-A1 Vitamin D derivatives with acyloxy groups in the side chains, process for their production, and the use for the production of pharmaceutical agents CYP24A1, CYP2R1, VDR F10 1485/4885HDAC1 2623/4885TUBB8B 4560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.